174 related articles for article (PubMed ID: 32089760)
1. Role of Oxycodone Hydrochloride in Treating Radiotherapy-Related Pain.
Wang Y; Xing L
Pain Res Manag; 2020; 2020():7565962. PubMed ID: 32089760
[TBL] [Abstract][Full Text] [Related]
2. Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer.
McDonald AM; Spencer SA; Willey CD; Bonner JA; Dobelbower MC; Swain TA; Nabell L; McCammon S; Carroll WR; McGwin G; Bhatia S; Yang ES
Support Care Cancer; 2021 Jan; 29(1):263-269. PubMed ID: 32350670
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
Sutou I; Nakatani T; Hashimoto T; Saito Y
J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):161-5. PubMed ID: 26095488
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial.
Hua X; Chen LM; Zhu Q; Hu W; Lin C; Long ZQ; Wen W; Sun XQ; Lu ZJ; Chen QY; Luo DH; Sun R; Mo HY; Tang LQ; Zhang WW; He ZY; Mai HQ; Lin HX; Guo L
Support Care Cancer; 2019 Oct; 27(10):3759-3767. PubMed ID: 30712098
[TBL] [Abstract][Full Text] [Related]
5. Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial.
Leng X; Zhang F; Yao S; Weng X; Lu K; Chen G; Huang M; Huang Y; Zeng X; Hopp M; Lu G
Adv Ther; 2020 Mar; 37(3):1188-1202. PubMed ID: 32020565
[TBL] [Abstract][Full Text] [Related]
6. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2015 Feb; (2):CD003870. PubMed ID: 25723351
[TBL] [Abstract][Full Text] [Related]
7. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
Ackerman SJ; Mordin M; Reblando J; Xu X; Schein J; Vallow S; Brennan M
J Manag Care Pharm; 2003; 9(3):223-31. PubMed ID: 14613465
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Oxycodone Hydrochloride (Strong Opioid) vs Combination Acetaminophen and Codeine (Mild Opioid) for Subacute Pain After Fractures Managed Surgically: A Randomized Clinical Trial.
Jenkin DE; Naylor JM; Descallar J; Harris IA
JAMA Netw Open; 2021 Nov; 4(11):e2134988. PubMed ID: 34787656
[TBL] [Abstract][Full Text] [Related]
10. [Oral controlled-release oxycodone for the treatment of chronic pain. Data from 4196 patients].
Gaertner J; Frank M; Bosse B; Sabatowski R; Elsner F; Giesecke T; Radbruch L
Schmerz; 2006 Feb; 20(1):61-8. PubMed ID: 15926076
[TBL] [Abstract][Full Text] [Related]
11. Oxycodone for Cancer Pain in Adult Patients.
Schmidt-Hansen M; Bennett MI; Hilgart J
JAMA; 2015 Sep 22-29; 314(12):1282-3. PubMed ID: 26393852
[TBL] [Abstract][Full Text] [Related]
12. Clinical study on fluvoxamine combined with oxycodone prolonged-release tablets in treating patients with moderate to severe cancer pain.
Xiao Y; Liu J; Huang XE; Ca LH; Ma YM; Wei W; Zhang RX; Huang XH; Chang J; Wu YJ
Asian Pac J Cancer Prev; 2014; 15(23):10445-9. PubMed ID: 25556490
[TBL] [Abstract][Full Text] [Related]
13. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.
Wiffen PJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD011056. PubMed ID: 24874470
[TBL] [Abstract][Full Text] [Related]
14. [Three cases of cancer-related pain for which oxycodone injection was efficacious].
Shinozaki K; Nitta T; Yamauchi M; Doi M
Gan To Kagaku Ryoho; 2013 Jan; 40(1):119-23. PubMed ID: 23306933
[TBL] [Abstract][Full Text] [Related]
15. Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice.
Schutter U; Grunert S; Meyer C; Schmidt T; Nolte T
Curr Med Res Opin; 2010 Jun; 26(6):1377-87. PubMed ID: 20380506
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of oxycodone against cancer-related pain with a wide variety of pathophysiologies].
Sumitani M; Yamada Y
Gan To Kagaku Ryoho; 2011 Jun; 38(6):977-82. PubMed ID: 21677490
[TBL] [Abstract][Full Text] [Related]
17. Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain.
Ravera E; Di Santo S; Bosco R; Arboscello C; Chiarlone R
Aging Clin Exp Res; 2011; 23(5-6):328-32. PubMed ID: 22526067
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study.
Dupoiron D; Stachowiak A; Loewenstein O; Ellery A; Kremers W; Bosse B; Hopp M
Eur J Pain; 2017 Oct; 21(9):1485-1494. PubMed ID: 28474460
[TBL] [Abstract][Full Text] [Related]
19. Oral Oxycodone for Acute Postoperative Pain: A Review of Clinical Trials.
Cheung CW; Ching Wong SS; Qiu Q; Wang X
Pain Physician; 2017 Feb; 20(2S):SE33-SE52. PubMed ID: 28226340
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain.
Pan H; Zhang Z; Zhang Y; Xu N; Lu L; Dou C; Guo Y; Wu S; Yue J; Wu D; Dai Y
Clin Drug Investig; 2007; 27(4):259-67. PubMed ID: 17358098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
